These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Efficacy of mexidol in the combination with thrombolytic therapy in patients with ischemic stroke]. Chefranova ZhIu; Makotrova TA; Udachin VA; Koledintseva EV Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(4):49-52. PubMed ID: 22810741 [TBL] [Abstract][Full Text] [Related]
4. [Antidepressant action of emoxipin and mexidol in mice with alloxan diabetes]. Volchegorskiĭ IA; Rassokhina LM; Miroshnichenko IIu Eksp Klin Farmakol; 2009; 72(2):11-5. PubMed ID: 19441720 [TBL] [Abstract][Full Text] [Related]
5. [The use of mexidol in urgent treatment of drug addiction]. Klindukhova OI; Novgorodov OE; Sergienko NN; Daniliuk PV; Belotserkovich OV Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(11):42-5. PubMed ID: 17176602 [TBL] [Abstract][Full Text] [Related]
6. ["Fast" and "slow" components of psychotropic activity of the drugs with nootropic effects]. Neznamov GG; Siuniakov SA; Davydova IA; Teleshova ES Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(6):33-7. PubMed ID: 10900686 [TBL] [Abstract][Full Text] [Related]
7. [Effect of semax and mexidol on brain ischemia models in rats]. Iasnetsov VV; Voronina TA Eksp Klin Farmakol; 2009; 72(1):68-70. PubMed ID: 19334516 [TBL] [Abstract][Full Text] [Related]
8. [The effects of Mexidol on food conditioning and synaptic fine structure of hippocampal field CA1 in rats exposed to a single acoustic stimulation with ultrasonic components]. Alekseeva TG; Loseva EV; Mering TA Zh Vyssh Nerv Deiat Im I P Pavlova; 2004; 54(2):269-76. PubMed ID: 15174273 [TBL] [Abstract][Full Text] [Related]
9. [Effect of mexidol on hemopoietic system in conditions of an emotional stress after exposure to ionizing radiation]. Moroz BB; Deshevoĭ IuB; Voronina TA; Lyrshchikova AV; Lebedev VG Radiats Biol Radioecol; 2007; 47(2):163-70. PubMed ID: 17571725 [TBL] [Abstract][Full Text] [Related]
10. [Effect sandostatin on functional and structural recovery of the central nervous system after clinical death]. Volkov AV; Gorenkova NA; Nazarenko IV; Avrushchenko MSh Anesteziol Reanimatol; 2003; (6):55-7. PubMed ID: 14991984 [TBL] [Abstract][Full Text] [Related]
11. [Neuropeptide role in the etiology, pathogenesis and clinical aspects of mental diseases]. Bakharev VD; Tikhomirov SM Sov Med; 1984; (6):50-3. PubMed ID: 6147020 [No Abstract] [Full Text] [Related]
12. [Characteristics of anxiety in patients of older age groups with different types of mild cognitive disorder]. Sidenkova AP Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):45-50. PubMed ID: 29265086 [TBL] [Abstract][Full Text] [Related]
13. [Mexidol: the spectrum of pharmacological effects]. Voronina TA Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(12):86-90. PubMed ID: 23461005 [No Abstract] [Full Text] [Related]
14. [Mexidol in treatment of children with generalized epilepsy and febrile seizures]. Natriashvili G; Natriashvili S; Kapanadze N Georgian Med News; 2005 May; (122):40-4. PubMed ID: 15988081 [TBL] [Abstract][Full Text] [Related]
15. [Relation between mexidol glucuronide conjugation and characteristics of its therapeutic effect in patients with organic lesions in the central nervous system]. Sariev AK; Davydova IA; Neznamov GG; Zherdev VP; Teleshova ES Eksp Klin Farmakol; 2001; 64(3):17-21. PubMed ID: 11558431 [TBL] [Abstract][Full Text] [Related]
16. [The effect of mexidol on the development of experimental peroxide athero-arteriosclerosis]. Deviatkina TA; Kovalenko EG; Smirnov LD Eksp Klin Farmakol; 1993; 56(1):33-5. PubMed ID: 8324470 [TBL] [Abstract][Full Text] [Related]
17. [The use of mexidol in psychiatric practice]. Kosenko VG; Karagezian EA; Luneva LV; Smolenko LF Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(6):38-41. PubMed ID: 16841482 [TBL] [Abstract][Full Text] [Related]
18. [Effect of mexidol (2-ethyl-6-methyl-3-oxypyridine succinate) on the quality of life and depressive symptoms in women with rheumatoid arthritis]. Sineglazova AV; Volchegorskiĭ IA Eksp Klin Farmakol; 2013; 76(1):7-10. PubMed ID: 23461008 [TBL] [Abstract][Full Text] [Related]
19. [Antioxidants in complex treatment of Parkinson's disease]. Katunina EA; Malykhina EA; Kuznetsov NV; Avakian GN; Gusev Ei; nerobkova LN; Voronina TA; Barskov IV Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(9):22-8. PubMed ID: 17069058 [TBL] [Abstract][Full Text] [Related]
20. [Development of postresuscitation morphological changes of hippocampal and cerebellar neurons: common regularities and specific features]. Avrushchenko MSh; Samorukova IV; Moroz VV; Volkov AV; Nazarenko IV; Gorenkova NA Patol Fiziol Eksp Ter; 2003; (2):27-30. PubMed ID: 12838772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]